Lennham Pharmaceuticals has filed a notice of an exempt offering of securities to raise $1,200,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Lennham Pharmaceuticals is raising $1,200,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Bradford Sippy played a key role…